Literature DB >> 7507076

Structure of the murine VCAM1 gene.

M I Cybulsky1, M Allan-Motamed, T Collins.   

Abstract

The architecture of the murine VCAM1 gene, encoding vascular cell adhesion molecule-1, was determined. its 10 exons span approximately 20 kb. Exon 1 encodes the 5' untranslated region and the signal peptide; exons 2-4 and 6-9, the C2 or H-type immunoglobulin domains; and exon 10, the transmembrane and cytoplasmic domains followed by the entire 3' untranslated region. All immunoglobulin-like domains are encoded by separate exons, and exon splice junctions occur after the first nucleotide of amino acid codons (type 1). Exon 5 encodes a novel domain unique to murine VCAM-1 and inclusion of this exon by alternative splicing results in a truncated three-immunoglobulin-like domain form, which is bound to the cell membrane by a phosphatidylinositol linkage at its carboxy terminus (encoded by exon 5). The murine VCAM1 core promoter contains a high degree of homology to the human, including conserved consensus binding sites for NF-kappa B, the Ets class, and the GATA family of transcription factors, suggesting that the murine and human VCAM1 genes may be under similar transcriptional control.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507076     DOI: 10.1006/geno.1993.1480

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

1.  Differential role of an NF-κB transcriptional response element in endothelial versus intimal cell VCAM-1 expression.

Authors:  David S Milstone; Motoi Ilyama; Mian Chen; Peter O'Donnell; Vannessa M Davis; Jorge Plutzky; Jonathan D Brown; Saptarsi M Haldar; Allan Siu; Andrew C Lau; Su-Ning Zhu; Mayada F Basheer; Tucker Collins; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  Circ Res       Date:  2015-06-01       Impact factor: 17.367

2.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

Authors:  M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI-3K/Akt-NF-kappaB signaling pathway.

Authors:  Qiangsong Tong; Liduan Zheng; Li Lin; Bo Li; Danming Wang; Dechun Li
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-18       Impact factor: 6.914

4.  Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Exp Hematol       Date:  2008-10-25       Impact factor: 3.084

5.  Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro.

Authors:  Raktima Bhattacharya; Berit Osburg; Dagmar Fischer; Ulrich Bickel
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

6.  Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.

Authors:  T Nishiyama; K Mishima; K Obara; H Inoue; T Doi; S Kondo; M Saka; Y Tabunoki; Y Hattori; T Kodama; K Tsubota; I Saito
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

7.  Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1.

Authors:  A S Neish; M A Read; D Thanos; R Pine; T Maniatis; T Collins
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response.

Authors:  C E Leuker; M Labow; W Müller; N Wagner
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

Review 9.  Endothelial activation: intracellular signaling pathways.

Authors:  Jordan S Pober
Journal:  Arthritis Res       Date:  2002-05-09

10.  Myogenin is required for late but not early aspects of myogenesis during mouse development.

Authors:  J M Venuti; J H Morris; J L Vivian; E N Olson; W H Klein
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.